Abstract
Although cell transfection by viral vectors is highly efficient, undesirable side effects including immunogenicity, toxicity and carcinogenesis have to be taken into consideration before their clinical applications. In contrast, most nonviral vectors, such as chitosan, are advantageous due to their biocompatibility, biodegradability, low toxicity and immunogenicity. However, the tranfection efficiency of chitosan as gene vector is rather low because of its low stability and low buffering capacity. Recent technological progress in chemical modification of chitosan has led to improvements of its transfection efficiency without disturbing its biocompatibility and biodegradability. These advances have led to a better understanding of the relationship between the physicochemical characteristics of a non-viral vector and its transfection efficiency. In this review, we summarize the obstacles encountered during the transfection process of chitosan and its derivatives, and then focus on strategies to overcome these obstacles. An accurate method for determining the rate-limiting step and intracellular unpacking kinetics of chitosan and its derivatives is also presented. Lastly, gene-silencing chitosan/ small interfering RNA (chitosan/siRNA) complexes and prospects of feasible methods for enhancing the transfection efficiency of chitosan and its derivatives are discussed.
Keywords: Chemical modification, biological reconstruction, rate-limiting step, chitosan/siRNA complex
Current Gene Therapy
Title: Progress and Prospects of Chitosan and Its Derivatives as Non-Viral Gene Vectors in Gene Therapy
Volume: 9 Issue: 6
Author(s): Haijun Tong, Qin Shi, Julio C. Fernandes, Li Liu, Kerong Dai and Xiaoling Zhang
Affiliation:
Keywords: Chemical modification, biological reconstruction, rate-limiting step, chitosan/siRNA complex
Abstract: Although cell transfection by viral vectors is highly efficient, undesirable side effects including immunogenicity, toxicity and carcinogenesis have to be taken into consideration before their clinical applications. In contrast, most nonviral vectors, such as chitosan, are advantageous due to their biocompatibility, biodegradability, low toxicity and immunogenicity. However, the tranfection efficiency of chitosan as gene vector is rather low because of its low stability and low buffering capacity. Recent technological progress in chemical modification of chitosan has led to improvements of its transfection efficiency without disturbing its biocompatibility and biodegradability. These advances have led to a better understanding of the relationship between the physicochemical characteristics of a non-viral vector and its transfection efficiency. In this review, we summarize the obstacles encountered during the transfection process of chitosan and its derivatives, and then focus on strategies to overcome these obstacles. An accurate method for determining the rate-limiting step and intracellular unpacking kinetics of chitosan and its derivatives is also presented. Lastly, gene-silencing chitosan/ small interfering RNA (chitosan/siRNA) complexes and prospects of feasible methods for enhancing the transfection efficiency of chitosan and its derivatives are discussed.
Export Options
About this article
Cite this article as:
Tong Haijun, Shi Qin, Fernandes C. Julio, Liu Li, Dai Kerong and Zhang Xiaoling, Progress and Prospects of Chitosan and Its Derivatives as Non-Viral Gene Vectors in Gene Therapy, Current Gene Therapy 2009; 9 (6) . https://dx.doi.org/10.2174/156652309790031111
DOI https://dx.doi.org/10.2174/156652309790031111 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional
Uses and Extensive Phytochemistry: A Review
Current Drug Discovery Technologies Nonviral Gene Therapy
Current Gene Therapy Progress in the Rational Design for Polypharmacology Drug
Current Pharmaceutical Design Treatment of Psoriasis: A Comprehensive Review of Entire Therapies
Current Drug Safety Recent Patents on Nucleic Acid-Based Antiviral Therapeutics
Recent Patents on Anti-Infective Drug Discovery Lipid-based Nano-phytomedicines for Disease Treatment and Theranostic Applications
Current Nanomedicine Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
Current Medicinal Chemistry Neuropeptide Mimetics and Antagonists in the Treatment of Inflammatory Disease: Focus on VIP and PACAP
Current Topics in Medicinal Chemistry Anti-inflammatory, Antioxidant, Lung and Liver Protective Activity of <i>Galaxaura oblongata</i> as Antagonistic Efficacy against LPS using Hematological Parameters and Immunohistochemistry as Biomarkers
Cardiovascular & Hematological Agents in Medicinal Chemistry Psychotropics and Fertility
Current Women`s Health Reviews Phytochemistry, Traditional Uses and Bioactivity of the Medicinal Plant Schinus areira L. (Anacardiaceae): A Review
The Natural Products Journal Cardiovascular Imaging in Thromboembolic Risk Stratification for Atrial Fibrillation: Recent Patents and Current Practice
Recent Patents on Medical Imaging Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-based Role in Disease Management
Recent Patents on Anti-Cancer Drug Discovery Mechanisms of Brain Signaling During Sepsis
Current Neuropharmacology Infection and Hemodialysis Access: An Updated Review.
Infectious Disorders - Drug Targets Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People
Current Pharmaceutical Design Heart Infection Prognosis Analysis by Two-dimensional Spot Tracking Imaging
Current Medical Imaging <i>In vitro</i> Anti-HIV-1 Activity of the Recombinant HIV-1 TAT Protein Along With Tenofovir Drug
Current HIV Research Lipid Matrix Nanoparticles: Pharmacokinetics and Biopharmaceutics
Current Nanoscience Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design